| Year | Event |
|---|
| 2003 | NIDA releases Preventing Drug Abuse among Children and Adolescents: A Research-Based Guide for Parents, Teachers and Educators, Second Edition, adding two new prevention principles to its popular first release and offering an In Brief edition and laminated set of Pocket Principles.
|
| 2003 | NIDA launches its interactive Web site, "NIDA for Teens: The Science Behind Drug Abuse," targeting teens age 11-15. Content is based partly on the highly successful Heads Up campaign that reaches more than 8 million younger students each year.
|
| 2002 | NIDA adds three additional research nodes to its National Drug Abuse Clinical Trials Network, increasing the number of nodes to 17 and the number of community treatment programs to more than 80.
|
| 2002 | NIDA releases a new elementary school curriculum "Brain Power! The NIDA Junior Scientist Program," for use in second- and third-grade classrooms.
|
| 2002 | NIDA teams with Scholastic, a leading provider of educational materials for children and teachers, in launching a project to bring science-based information about drug abuse to millions of U.S. school children.
|
2002 | Buprenorphine, developed with NIDA's support, is approved for the treatment of opiate addiction. |
| 2002 | NIDA releases Principles of HIV Prevention in Drug-Using Populations: A Research-Based Guide, to prevent spread of HIV. |
| 2001 | NIDA adds four additional research nodes to its National Drug Abuse Clinical Trials Network, increasing the number of nodes from the original 6 to 14 and the number of community treatment programs to more than 80.
|
| 2000 | NIDA distributes its Clinical Toolbox, a collection
of the latest comprehensive science-based publications and other materials on drug addiction and its treatment, to the nearly 12,000 drug treatment programs nationwide. |
| 1999 | NIDA, the National Cancer Institute (NCI), and The Robert Wood Johnson Foundation award grants to seven academic research institutions to establish Transdisciplinary Tobacco Use Research Centers to investigate new ways to combat tobacco use and nicotine addiction. |
| 1999 | NIDA releases Principles of Treatment: A Research-Based Guide which describes the overarching principles for the most effective treatment of drug addiction. |
| 1999 | NIDA launches the National Drug Abuse Treatment Clinical Trials Network to rapidly and efficiently test the effectiveness of behavioral and pharmacological treatments in real-life settings. |
| 1998 | NIDA establishes the Center on AIDS and Other Medical Consequences of Drug Abuse to coordinate a multidisciplinary research program on drug abuse and HIV/AIDS and other health consequences of drug abuse and addiction. |
| 1998 | NIDA produces and distributes "NIDA Goes to School," a science education package on drugs of abuse for students in grades five through nine. |
| 1997 | NIDA releases Preventing Drug Use Among Children and Adolescents: A Research-Based Guide, the first research-based guide to preventing young people from using drugs. |
| 1997 | NIDA launches the annual PRISM awards for accurate depiction of drugs, alcohol, and tobacco in feature films and television productions. |
| 1995 | NIDA researchers clone the dopamine transporter -- cocaine's primary site of action in the brain. |
| 1992 | NIDA joins the National Institutes of Health, the world's premier biomedical and behavioral research agency. |
| 1990 | NIDA establishes its Medications Development Program to focus efforts on new pharmacotherapies to treat drug addiction. |
| 1988 | Congress further increases NIDA funding for treatment research, research on the maternal and fetal effects of drugs, and medications development. |
| 1986 | The dual epidemics of drug abuse and HIV/AIDS are recognized by Congress and the Administration in a quadrupling of NIDA funding for research on both major diseases. |
| 1981 | NIDA's mission changes as Congress legislates the Block Grant Program to give States more control over drug abuse treatment and prevention services. |
| 1974 | NIDA is established as the Federal focal point for research, treatment, prevention and training services, and data collection on the nature and extent of drug abuse. |
